Myeloproliferative neoplasms (MPNs) – Part 2: A nursing guide to managing the symptom burden of MPNs
<p class="p1">Myeloproliferative neoplasms (MPNs) are rare, yet potentially life-threatening, disorders caused by overproliferation of bone marrow stem cells. The symptom burden experienced by patients with the BCR-ABL1-negative MPNs (also referred to as the classical MPNs, i.e., ess...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pappin Communications
2018-10-01
|
| Series: | Canadian Oncology Nursing Journal |
| Online Access: | https://canadianoncologynursingjournal.com/index.php/conj/article/view/931 |
| _version_ | 1797319824375808000 |
|---|---|
| author | Sabrina Fowlkes Cindy Murray Adrienne Fulford Tammy De Gelder Nancy Siddiq |
| author_facet | Sabrina Fowlkes Cindy Murray Adrienne Fulford Tammy De Gelder Nancy Siddiq |
| author_sort | Sabrina Fowlkes |
| collection | DOAJ |
| description | <p class="p1">Myeloproliferative neoplasms (MPNs) are rare, yet potentially life-threatening, disorders caused by overproliferation of bone marrow stem cells. The symptom burden experienced by patients with the BCR-ABL1-negative MPNs (also referred to as the classical MPNs, i.e., essential thrombocythemia [ET], polycythemia vera [PV] and myelofibrosis [MF]) can be significant and can negatively impact quality of life (QOL). Since patients with these MPNs can live for several years, thereby requiring long-term treatment and follow-up, nurses play an essential role in communicating with these patients, assessing their symptoms, and educating them on treatments and self-management strategies that can reduce their symptom burden. This article, which is the second of a two-part series, was developed to provide nurses and other healthcare professionals with practical guidance for managing the symptom burden associated with the classical MPNs in order to help enhance their patients’ overall health and QOL.</p> |
| first_indexed | 2024-03-08T04:13:38Z |
| format | Article |
| id | doaj.art-7e175a404ebf4e1c9f091633478905dc |
| institution | Directory Open Access Journal |
| issn | 1181-912X 2368-8076 |
| language | English |
| last_indexed | 2024-03-08T04:13:38Z |
| publishDate | 2018-10-01 |
| publisher | Pappin Communications |
| record_format | Article |
| series | Canadian Oncology Nursing Journal |
| spelling | doaj.art-7e175a404ebf4e1c9f091633478905dc2024-02-08T16:29:00ZengPappin CommunicationsCanadian Oncology Nursing Journal1181-912X2368-80762018-10-01284276281835Myeloproliferative neoplasms (MPNs) – Part 2: A nursing guide to managing the symptom burden of MPNsSabrina FowlkesCindy MurrayAdrienne FulfordTammy De GelderNancy Siddiq<p class="p1">Myeloproliferative neoplasms (MPNs) are rare, yet potentially life-threatening, disorders caused by overproliferation of bone marrow stem cells. The symptom burden experienced by patients with the BCR-ABL1-negative MPNs (also referred to as the classical MPNs, i.e., essential thrombocythemia [ET], polycythemia vera [PV] and myelofibrosis [MF]) can be significant and can negatively impact quality of life (QOL). Since patients with these MPNs can live for several years, thereby requiring long-term treatment and follow-up, nurses play an essential role in communicating with these patients, assessing their symptoms, and educating them on treatments and self-management strategies that can reduce their symptom burden. This article, which is the second of a two-part series, was developed to provide nurses and other healthcare professionals with practical guidance for managing the symptom burden associated with the classical MPNs in order to help enhance their patients’ overall health and QOL.</p>https://canadianoncologynursingjournal.com/index.php/conj/article/view/931 |
| spellingShingle | Sabrina Fowlkes Cindy Murray Adrienne Fulford Tammy De Gelder Nancy Siddiq Myeloproliferative neoplasms (MPNs) – Part 2: A nursing guide to managing the symptom burden of MPNs Canadian Oncology Nursing Journal |
| title | Myeloproliferative neoplasms (MPNs) – Part 2: A nursing guide to managing the symptom burden of MPNs |
| title_full | Myeloproliferative neoplasms (MPNs) – Part 2: A nursing guide to managing the symptom burden of MPNs |
| title_fullStr | Myeloproliferative neoplasms (MPNs) – Part 2: A nursing guide to managing the symptom burden of MPNs |
| title_full_unstemmed | Myeloproliferative neoplasms (MPNs) – Part 2: A nursing guide to managing the symptom burden of MPNs |
| title_short | Myeloproliferative neoplasms (MPNs) – Part 2: A nursing guide to managing the symptom burden of MPNs |
| title_sort | myeloproliferative neoplasms mpns part 2 a nursing guide to managing the symptom burden of mpns |
| url | https://canadianoncologynursingjournal.com/index.php/conj/article/view/931 |
| work_keys_str_mv | AT sabrinafowlkes myeloproliferativeneoplasmsmpnspart2anursingguidetomanagingthesymptomburdenofmpns AT cindymurray myeloproliferativeneoplasmsmpnspart2anursingguidetomanagingthesymptomburdenofmpns AT adriennefulford myeloproliferativeneoplasmsmpnspart2anursingguidetomanagingthesymptomburdenofmpns AT tammydegelder myeloproliferativeneoplasmsmpnspart2anursingguidetomanagingthesymptomburdenofmpns AT nancysiddiq myeloproliferativeneoplasmsmpnspart2anursingguidetomanagingthesymptomburdenofmpns |